glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. “Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) Assessing Thyroid Cancer Risk With
Pay in 4 interest-free payments of $6.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) Assessing Thyroid Cancer Risk With](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/cd1a15e7741f2ca2db332caf387600b1c30916d1-480x600.jpg)
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) Assessing Thyroid Cancer Risk With](https://www.mdpi.com/biomolecules/biomolecules-14-00687/article_deploy/html/images/biomolecules-14-00687-g001-550.jpg)
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) Assessing Thyroid Cancer Risk With](https://www.researchgate.net/publication/335217900/figure/fig2/AS:962700993634322@1606537211935/Forest-plot-of-GLP-1-receptor-agonists-versus-comparators-on-risk-of-thyroid-cancer-a.png)
![glp-1 agonists thyroid cancer Ozempic and Wegovy increase risk of cancer. Use of RA for 1-3 years was associated with increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) Assessing Thyroid Cancer Risk With](https://www.musechem.com/wp-content/uploads/2026/07/109c9670-806d-42f9-b57f-fa9af870deb0.png)






















